Patrick R Lawler
Overview
Explore the profile of Patrick R Lawler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
184
Citations
5756
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Varshney A, Palazzolo M, Barnett C, Bohula E, Burke J, Chaudhry S, et al.
J Card Fail
. 2025 Feb;
PMID: 40015594
Background: The epidemiology and prognostic significance of acute non-cardiac organ dysfunction across cardiogenic shock (CS) subtypes are not well-defined. Methods: CS admissions from 2017-2022 in the Critical Care Cardiology Trials...
2.
Brahmbhatt D, Scolari F, Fung N, Otsuki M, Lawler P, Ross H, et al.
ESC Heart Fail
. 2025 Feb;
PMID: 39925014
Aims: The inflammatory profile of cardiogenic shock (CS) after myocardial infarction affects outcomes; however, little is known about the impact of inflammatory changes in CS caused by acute decompensated heart...
3.
Soussi S, Price S, Proudfoot A, Mebazaa A, Lawler P
Am J Respir Crit Care Med
. 2025 Jan;
211(3):319-322.
PMID: 39805090
No abstract available.
4.
Soussi S, Tarvasmaki T, Kimmoun A, Ahmadiankalati M, Azibani F, Santos C, et al.
EClinicalMedicine
. 2025 Jan;
79():103013.
PMID: 39802301
Background: Cardiogenic shock (CS) is a heterogeneous clinical syndrome, making it challenging to predict patient trajectory and response to treatment. This study aims to identify biological/molecular CS subphenotypes, evaluate their...
5.
Skove S, Berg D, Bohula E, Guo J, Alfonso C, Barsness G, et al.
Circ Heart Fail
. 2025 Jan;
18(2):e012109.
PMID: 39772549
No abstract available.
6.
Wahid L, Froess J, Ortel T, Zarychanski R, Berger J, Cushman M, et al.
Arterioscler Thromb Vasc Biol
. 2024 Dec;
45(1):162-164.
PMID: 39633573
No abstract available.
7.
Tamura T, Cheng C, Villasenor-Altamirano A, Yamada K, Ikeda K, Hayashida K, et al.
Sci Transl Med
. 2024 Dec;
16(776):eadq5796.
PMID: 39630883
Neurological injury drives most deaths and morbidity among patients hospitalized for out-of-hospital cardiac arrest (OHCA). Despite its clinical importance, there are no effective pharmacological therapies targeting post-cardiac arrest (CA) neurological...
8.
Mortality After Multivessel Revascularization in Patients With Diabetes and Acute Coronary Syndromes
Godoy L, Farkouh M, Austin P, Shah B, Qiu F, Sud M, et al.
JACC Adv
. 2024 Oct;
3(9):101203.
PMID: 39372470
Background: The optimal revascularization strategy in patients with diabetes and multivessel disease in the setting of a non-ST-segment elevation myocardial infarction (NSTEMI) is unknown. Objectives: The purpose of this study...
9.
10.
Lother S, Tennenhouse L, Rabbani R, Abou-Setta A, Askin N, Turgeon A, et al.
Res Pract Thromb Haemost
. 2024 Sep;
8(5):102526.
PMID: 39262648
Background: Community-acquired pneumonia (CAP) triggers inflammatory and thrombotic host responses driving morbidity and mortality. Antiplatelet agents may favorably modulate these pathways; however, their role in non-COVID-19 CAP remains uncertain. Objectives:...